

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.58090263 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.24752665 |
| 3 | axonemal dynein complex assembly (GO:0070286) | 4.23963552 |
| 4 | synaptic vesicle maturation (GO:0016188) | 4.12701478 |
| 5 | vocalization behavior (GO:0071625) | 4.02733993 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.97681165 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 3.96939909 |
| 8 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.95829343 |
| 9 | glutamate secretion (GO:0014047) | 3.94650430 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.92782163 |
| 11 | locomotory exploration behavior (GO:0035641) | 3.78823927 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.71106294 |
| 13 | neuronal action potential propagation (GO:0019227) | 3.66714842 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.59701327 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.54989275 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.40533279 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 3.39661823 |
| 18 | protein localization to synapse (GO:0035418) | 3.34709783 |
| 19 | neurotransmitter secretion (GO:0007269) | 3.34522468 |
| 20 | cellular potassium ion homeostasis (GO:0030007) | 3.33923332 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 3.23055962 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.19897321 |
| 23 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.19046790 |
| 24 | exploration behavior (GO:0035640) | 3.18497320 |
| 25 | proline transport (GO:0015824) | 3.17330374 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.14601653 |
| 27 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.13243949 |
| 28 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.13014708 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.11596883 |
| 30 | neuron recognition (GO:0008038) | 3.10421739 |
| 31 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.08639865 |
| 32 | vesicle transport along microtubule (GO:0047496) | 3.06901566 |
| 33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.03031146 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.01410681 |
| 35 | neuron-neuron synaptic transmission (GO:0007270) | 2.99627051 |
| 36 | positive regulation of Rap GTPase activity (GO:0032854) | 2.98747562 |
| 37 | regulation of vesicle fusion (GO:0031338) | 2.98409683 |
| 38 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.97210538 |
| 39 | mating behavior (GO:0007617) | 2.96416537 |
| 40 | neurotransmitter transport (GO:0006836) | 2.96408375 |
| 41 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.95392687 |
| 42 | sodium ion export (GO:0071436) | 2.94342532 |
| 43 | layer formation in cerebral cortex (GO:0021819) | 2.93477262 |
| 44 | dendritic spine morphogenesis (GO:0060997) | 2.92805720 |
| 45 | motile cilium assembly (GO:0044458) | 2.92644586 |
| 46 | synaptic transmission, glutamatergic (GO:0035249) | 2.89344206 |
| 47 | regulation of synapse structural plasticity (GO:0051823) | 2.88694686 |
| 48 | cilium movement (GO:0003341) | 2.87079912 |
| 49 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.85268661 |
| 50 | cerebellar granule cell differentiation (GO:0021707) | 2.84644779 |
| 51 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.84158301 |
| 52 | negative regulation of neurotransmitter transport (GO:0051589) | 2.84155096 |
| 53 | activation of protein kinase A activity (GO:0034199) | 2.80432999 |
| 54 | presynaptic membrane assembly (GO:0097105) | 2.79869493 |
| 55 | protein localization to endosome (GO:0036010) | 2.79797611 |
| 56 | transmission of nerve impulse (GO:0019226) | 2.78778040 |
| 57 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.78176629 |
| 58 | response to nerve growth factor (GO:1990089) | 2.78176629 |
| 59 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.75372802 |
| 60 | axonal fasciculation (GO:0007413) | 2.74518067 |
| 61 | regulation of postsynaptic membrane potential (GO:0060078) | 2.74212281 |
| 62 | regulation of neurotransmitter levels (GO:0001505) | 2.73669461 |
| 63 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.72593818 |
| 64 | gamma-aminobutyric acid transport (GO:0015812) | 2.71341963 |
| 65 | response to histamine (GO:0034776) | 2.70318825 |
| 66 | presynaptic membrane organization (GO:0097090) | 2.69790637 |
| 67 | regulation of neurotransmitter secretion (GO:0046928) | 2.67763657 |
| 68 | synaptic vesicle endocytosis (GO:0048488) | 2.65939613 |
| 69 | long-term memory (GO:0007616) | 2.65811361 |
| 70 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.65572191 |
| 71 | glycine transport (GO:0015816) | 2.65208105 |
| 72 | organelle transport along microtubule (GO:0072384) | 2.64750827 |
| 73 | multicellular organismal water homeostasis (GO:0050891) | 2.64292243 |
| 74 | neuromuscular process controlling posture (GO:0050884) | 2.64246625 |
| 75 | long-term synaptic potentiation (GO:0060291) | 2.62874334 |
| 76 | regulation of synaptic plasticity (GO:0048167) | 2.61314838 |
| 77 | synapse assembly (GO:0007416) | 2.60732696 |
| 78 | cellular sodium ion homeostasis (GO:0006883) | 2.59866973 |
| 79 | membrane depolarization during action potential (GO:0086010) | 2.59819871 |
| 80 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.59672951 |
| 81 | nerve growth factor signaling pathway (GO:0038180) | 2.59647831 |
| 82 | detection of calcium ion (GO:0005513) | 2.59365932 |
| 83 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.58512210 |
| 84 | adult walking behavior (GO:0007628) | 2.58476579 |
| 85 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.58319010 |
| 86 | regulation of water loss via skin (GO:0033561) | 2.58114521 |
| 87 | L-amino acid import (GO:0043092) | 2.56961099 |
| 88 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.56925468 |
| 89 | hypotonic response (GO:0006971) | 2.55302390 |
| 90 | membrane depolarization (GO:0051899) | 2.53010596 |
| 91 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.52782335 |
| 92 | regulation of Rap GTPase activity (GO:0032317) | 2.52770583 |
| 93 | positive regulation of fibroblast migration (GO:0010763) | 2.52759718 |
| 94 | protein targeting to Golgi (GO:0000042) | 2.52733735 |
| 95 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.52704680 |
| 96 | regulation of interleukin-13 production (GO:0032656) | 2.52591691 |
| 97 | cell communication involved in cardiac conduction (GO:0086065) | 2.52580350 |
| 98 | membrane hyperpolarization (GO:0060081) | 2.52161846 |
| 99 | regulation of neurotransmitter transport (GO:0051588) | 2.51874804 |
| 100 | dendrite morphogenesis (GO:0048813) | 2.51713190 |
| 101 | positive regulation of membrane potential (GO:0045838) | 2.51539350 |
| 102 | neuron remodeling (GO:0016322) | 2.51005457 |
| 103 | potassium ion homeostasis (GO:0055075) | 2.50809388 |
| 104 | establishment of skin barrier (GO:0061436) | 2.50427835 |
| 105 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.49363857 |
| 106 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.48914948 |
| 107 | desmosome organization (GO:0002934) | 2.48730706 |
| 108 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.48617151 |
| 109 | positive regulation of neurotransmitter transport (GO:0051590) | 2.48395745 |
| 110 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.46706835 |
| 111 | one-carbon compound transport (GO:0019755) | 2.45965511 |
| 112 | regulation of ARF protein signal transduction (GO:0032012) | 2.42635913 |
| 113 | behavioral response to cocaine (GO:0048148) | 2.42499096 |
| 114 | innervation (GO:0060384) | 2.40140828 |
| 115 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.40051205 |
| 116 | positive regulation of potassium ion transport (GO:0043268) | 2.39964135 |
| 117 | synaptic transmission (GO:0007268) | 2.37556523 |
| 118 | prepulse inhibition (GO:0060134) | 2.37358257 |
| 119 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.37265941 |
| 120 | axon ensheathment in central nervous system (GO:0032291) | 2.36626799 |
| 121 | central nervous system myelination (GO:0022010) | 2.36626799 |
| 122 | establishment of protein localization to Golgi (GO:0072600) | 2.36251814 |
| 123 | learning (GO:0007612) | 2.35318136 |
| 124 | potassium ion import (GO:0010107) | 2.32162127 |
| 125 | negative regulation of inclusion body assembly (GO:0090084) | 2.30464825 |
| 126 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.30414070 |
| 127 | macroautophagy (GO:0016236) | 2.28553690 |
| 128 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.28202670 |
| 129 | regulation of germinal center formation (GO:0002634) | 2.25377920 |
| 130 | myelin maintenance (GO:0043217) | 2.25227870 |
| 131 | regulation of interleukin-5 production (GO:0032674) | 2.23360908 |
| 132 | water homeostasis (GO:0030104) | 2.23003044 |
| 133 | sodium ion homeostasis (GO:0055078) | 2.21289538 |
| 134 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.19878752 |
| 135 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.18665810 |
| 136 | amino acid import (GO:0043090) | 2.13324936 |
| 137 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.13007446 |
| 138 | hemidesmosome assembly (GO:0031581) | 2.12860357 |
| 139 | tolerance induction (GO:0002507) | 2.11723966 |
| 140 | signal complex assembly (GO:0007172) | 2.11168317 |
| 141 | axoneme assembly (GO:0035082) | 2.08969312 |
| 142 | negative regulation of B cell mediated immunity (GO:0002713) | 2.08568082 |
| 143 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.08568082 |
| 144 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.06552576 |
| 145 | germinal center formation (GO:0002467) | 2.05182450 |
| 146 | cell communication by electrical coupling (GO:0010644) | 2.05098620 |
| 147 | import into cell (GO:0098657) | 2.03759248 |
| 148 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.01688166 |
| 149 | surfactant homeostasis (GO:0043129) | 2.01114321 |
| 150 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.01059996 |
| 151 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.00004340 |
| 152 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.97931882 |
| 153 | cellular response to antibiotic (GO:0071236) | 1.97324312 |
| 154 | negative regulation of hormone metabolic process (GO:0032351) | 1.93120731 |
| 155 | negative regulation of hormone biosynthetic process (GO:0032353) | 1.91720339 |
| 156 | cell volume homeostasis (GO:0006884) | 1.90780167 |
| 157 | positive regulation of vesicle fusion (GO:0031340) | 1.90045043 |
| 158 | Golgi to endosome transport (GO:0006895) | 1.89540484 |
| 159 | relaxation of cardiac muscle (GO:0055119) | 1.89460659 |
| 160 | regulation of RIG-I signaling pathway (GO:0039535) | 1.89414382 |
| 161 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 1.89382490 |
| 162 | cellular response to epinephrine stimulus (GO:0071872) | 1.88766275 |
| 163 | iron ion import (GO:0097286) | 1.88663257 |
| 164 | regulation of gamma-delta T cell differentiation (GO:0045586) | 1.88191864 |
| 165 | regulation of beta-amyloid formation (GO:1902003) | 1.87634660 |
| 166 | positive regulation of cellular amide metabolic process (GO:0034250) | 1.87384168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.14683886 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15819188 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.85792809 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.70002526 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.67312583 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.54909910 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.34916550 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.32366480 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.26145234 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.26145234 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24692829 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24547107 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.24292530 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23292564 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.15605868 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.15504038 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08622286 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.05546526 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.01337467 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.00090374 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93476115 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.91833791 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.90020328 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.88122161 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.82608296 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81541430 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.70656477 |
| 28 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65023275 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64753212 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61941031 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.59198839 |
| 32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57359334 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56432545 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55376968 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54185356 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53858875 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52366839 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52207020 |
| 39 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50136686 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49614535 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.48751928 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47682395 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.47099673 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46509952 |
| 45 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.45768634 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45705064 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44510179 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.44438010 |
| 49 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42820871 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42154537 |
| 51 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.40424028 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38167835 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.38159210 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38035651 |
| 55 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37002003 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.35660435 |
| 57 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35209700 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35186189 |
| 59 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.35008888 |
| 60 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33293768 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.32529099 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32506499 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32346306 |
| 64 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31594381 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31017793 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30924206 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30138067 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29268235 |
| 69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.27682235 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27568775 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27316383 |
| 72 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27224190 |
| 73 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26551796 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26168023 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26122858 |
| 76 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25490928 |
| 77 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23998263 |
| 78 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22707110 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.22277941 |
| 80 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20804587 |
| 81 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19686078 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19459970 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18501072 |
| 84 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.17827580 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17160421 |
| 86 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.16195453 |
| 87 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15004101 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13572458 |
| 89 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12447015 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11489265 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11362193 |
| 92 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11257199 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10190112 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09994454 |
| 95 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.09003230 |
| 96 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08862847 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08297225 |
| 98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07969927 |
| 99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07806518 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07507132 |
| 101 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.07150155 |
| 102 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06698318 |
| 103 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06039824 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05727962 |
| 105 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05541836 |
| 106 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05338042 |
| 107 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04776208 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04700710 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04246991 |
| 110 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03400835 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03379974 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03264114 |
| 113 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02935400 |
| 114 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02387856 |
| 115 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02334442 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02014615 |
| 117 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.01788599 |
| 118 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.01024179 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01022500 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00964528 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00684400 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00595402 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.99775328 |
| 124 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99555567 |
| 125 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98436329 |
| 126 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97394730 |
| 127 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97209935 |
| 128 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97130976 |
| 129 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97123404 |
| 130 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97083210 |
| 131 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96646014 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96471116 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96235698 |
| 134 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95717284 |
| 135 | AR_19668381_ChIP-Seq_PC3_Human | 0.94882733 |
| 136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94588971 |
| 137 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94425426 |
| 138 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94425426 |
| 139 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93955560 |
| 140 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93707929 |
| 141 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93458918 |
| 142 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92943297 |
| 143 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92746581 |
| 144 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92364275 |
| 145 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92067878 |
| 146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92042138 |
| 147 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91991290 |
| 148 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91656717 |
| 149 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91656717 |
| 150 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91203945 |
| 151 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91091410 |
| 152 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91032668 |
| 153 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90978419 |
| 154 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.90681392 |
| 155 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89689042 |
| 156 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89501096 |
| 157 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.89177320 |
| 158 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86600032 |
| 159 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86423211 |
| 160 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86235833 |
| 161 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82837483 |
| 162 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81834502 |
| 163 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.81603558 |
| 164 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81375021 |
| 165 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80425306 |
| 166 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79603465 |
| 167 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.79580935 |
| 168 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78249404 |
| 169 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78249404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.93057761 |
| 2 | MP0003880_abnormal_central_pattern | 4.53376155 |
| 3 | MP0004270_analgesia | 3.66110796 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.50235233 |
| 5 | MP0009745_abnormal_behavioral_response | 2.94753128 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.86590517 |
| 7 | MP0002064_seizures | 2.85584895 |
| 8 | MP0009046_muscle_twitch | 2.78125725 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.70568788 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.59577638 |
| 11 | MP0002822_catalepsy | 2.51958231 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.49990654 |
| 13 | MP0002272_abnormal_nervous_system | 2.47956842 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.44499765 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.42961347 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.41819748 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.38715118 |
| 18 | MP0001486_abnormal_startle_reflex | 2.25069570 |
| 19 | MP0002736_abnormal_nociception_after | 2.23296078 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.14790458 |
| 21 | MP0003303_peritoneal_inflammation | 2.12509190 |
| 22 | MP0001970_abnormal_pain_threshold | 2.11230150 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.06171629 |
| 24 | MP0006276_abnormal_autonomic_nervous | 2.04238415 |
| 25 | MP0003329_amyloid_beta_deposits | 2.00704412 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.95874109 |
| 27 | MP0003453_abnormal_keratinocyte_physiol | 1.88987898 |
| 28 | MP0008004_abnormal_stomach_pH | 1.87928377 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.84236110 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.82621068 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.80087857 |
| 32 | MP0004947_skin_inflammation | 1.79080467 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.75420807 |
| 34 | MP0004858_abnormal_nervous_system | 1.70853262 |
| 35 | MP0008569_lethality_at_weaning | 1.69061097 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.65415327 |
| 37 | MP0004924_abnormal_behavior | 1.65415327 |
| 38 | MP0002184_abnormal_innervation | 1.63802035 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.63661274 |
| 40 | MP0000778_abnormal_nervous_system | 1.57709810 |
| 41 | MP0000920_abnormal_myelination | 1.57325843 |
| 42 | MP0001790_abnormal_immune_system | 1.56228643 |
| 43 | MP0005387_immune_system_phenotype | 1.56228643 |
| 44 | MP0001905_abnormal_dopamine_level | 1.52446859 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.51604208 |
| 46 | MP0002557_abnormal_social/conspecific_i | 1.49681041 |
| 47 | MP0001984_abnormal_olfaction | 1.49553103 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.46346703 |
| 49 | MP0004885_abnormal_endolymph | 1.43444807 |
| 50 | MP0003633_abnormal_nervous_system | 1.41818566 |
| 51 | MP0004811_abnormal_neuron_physiology | 1.40399254 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.40118946 |
| 53 | MP0000383_abnormal_hair_follicle | 1.38013088 |
| 54 | MP0004264_abnormal_extraembryonic_tissu | 1.37183935 |
| 55 | MP0001529_abnormal_vocalization | 1.36614471 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.35982716 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.33153730 |
| 58 | MP0005166_decreased_susceptibility_to | 1.33022013 |
| 59 | MP0003724_increased_susceptibility_to | 1.32780948 |
| 60 | MP0000955_abnormal_spinal_cord | 1.31463851 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.31043662 |
| 62 | MP0002796_impaired_skin_barrier | 1.28363379 |
| 63 | MP0001851_eye_inflammation | 1.25600481 |
| 64 | MP0003879_abnormal_hair_cell | 1.25356660 |
| 65 | MP0004142_abnormal_muscle_tone | 1.24745046 |
| 66 | MP0004742_abnormal_vestibular_system | 1.23480551 |
| 67 | MP0006082_CNS_inflammation | 1.22622440 |
| 68 | MP0002882_abnormal_neuron_morphology | 1.22163472 |
| 69 | MP0003690_abnormal_glial_cell | 1.21360049 |
| 70 | MP0004381_abnormal_hair_follicle | 1.20800471 |
| 71 | MP0003787_abnormal_imprinting | 1.20688212 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.19946244 |
| 73 | MP0003631_nervous_system_phenotype | 1.14819124 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.14003046 |
| 75 | MP0001502_abnormal_circadian_rhythm | 1.12189299 |
| 76 | MP0000604_amyloidosis | 1.10613140 |
| 77 | MP0008260_abnormal_autophagy | 1.10279116 |
| 78 | MP0002229_neurodegeneration | 1.10041481 |
| 79 | MP0001664_abnormal_digestion | 1.08380245 |
| 80 | MP0003634_abnormal_glial_cell | 1.07099996 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 1.05623430 |
| 82 | MP0002837_dystrophic_cardiac_calcinosis | 1.04032823 |
| 83 | MP0005058_abnormal_lysosome_morphology | 1.03363573 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.02475096 |
| 85 | MP0001835_abnormal_antigen_presentation | 1.01360668 |
| 86 | MP0005000_abnormal_immune_tolerance | 0.99447799 |
| 87 | MP0004510_myositis | 0.98627864 |
| 88 | MP0002166_altered_tumor_susceptibility | 0.98532753 |
| 89 | MP0005310_abnormal_salivary_gland | 0.97945978 |
| 90 | MP0001188_hyperpigmentation | 0.96846891 |
| 91 | MP0005165_increased_susceptibility_to | 0.96466677 |
| 92 | MP0005409_darkened_coat_color | 0.96251294 |
| 93 | MP0001216_abnormal_epidermal_layer | 0.95747653 |
| 94 | MP0000685_abnormal_immune_system | 0.95237359 |
| 95 | MP0008874_decreased_physiological_sensi | 0.94095138 |
| 96 | MP0003091_abnormal_cell_migration | 0.93855382 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.93073556 |
| 98 | MP0003045_fibrosis | 0.93064471 |
| 99 | MP0000569_abnormal_digit_pigmentation | 0.93059546 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.92752538 |
| 101 | MP0008872_abnormal_physiological_respon | 0.92566597 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.92018353 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.91072716 |
| 104 | MP0010678_abnormal_skin_adnexa | 0.90456703 |
| 105 | MP0003436_decreased_susceptibility_to | 0.90196093 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.89315169 |
| 107 | MP0005501_abnormal_skin_physiology | 0.88739032 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.88405343 |
| 109 | MP0005671_abnormal_response_to | 0.88099725 |
| 110 | MP0004019_abnormal_vitamin_homeostasis | 0.87723856 |
| 111 | MP0001800_abnormal_humoral_immune | 0.87449250 |
| 112 | MP0000751_myopathy | 0.86237757 |
| 113 | MP0005025_abnormal_response_to | 0.85891696 |
| 114 | MP0005535_abnormal_body_temperature | 0.85314264 |
| 115 | MP0003632_abnormal_nervous_system | 0.83811260 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.83510785 |
| 117 | MP0005551_abnormal_eye_electrophysiolog | 0.82660431 |
| 118 | MP0003075_altered_response_to | 0.79729015 |
| 119 | MP0002098_abnormal_vibrissa_morphology | 0.79186372 |
| 120 | MP0002090_abnormal_vision | 0.78548486 |
| 121 | MP0004085_abnormal_heartbeat | 0.77597773 |
| 122 | MP0001177_atelectasis | 0.77517525 |
| 123 | MP0001881_abnormal_mammary_gland | 0.75510420 |
| 124 | MP0003828_pulmonary_edema | 0.74555191 |
| 125 | MP0002069_abnormal_eating/drinking_beha | 0.72201212 |
| 126 | MP0003122_maternal_imprinting | 0.71920748 |
| 127 | MP0004484_altered_response_of | 0.71282304 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.70943214 |
| 129 | MP0002152_abnormal_brain_morphology | 0.70738521 |
| 130 | MP0000579_abnormal_nail_morphology | 0.69900512 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.67917050 |
| 132 | MP0000538_abnormal_urinary_bladder | 0.67560444 |
| 133 | MP0001963_abnormal_hearing_physiology | 0.67038099 |
| 134 | MP0004145_abnormal_muscle_electrophysio | 0.64291193 |
| 135 | MP0004043_abnormal_pH_regulation | 0.64203960 |
| 136 | MP0005499_abnormal_olfactory_system | 0.62833250 |
| 137 | MP0005394_taste/olfaction_phenotype | 0.62833250 |
| 138 | MP0003866_abnormal_defecation | 0.62392026 |
| 139 | MP0002752_abnormal_somatic_nervous | 0.62391224 |
| 140 | MP0002009_preneoplasia | 0.62106022 |
| 141 | MP0001485_abnormal_pinna_reflex | 0.61418300 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.60960911 |
| 143 | MP0001348_abnormal_lacrimal_gland | 0.58830272 |
| 144 | MP0010771_integument_phenotype | 0.57055986 |
| 145 | MP0005623_abnormal_meninges_morphology | 0.54271666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.21246375 |
| 2 | Myokymia (HP:0002411) | 5.40356224 |
| 3 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.09201262 |
| 4 | Focal seizures (HP:0007359) | 4.74018946 |
| 5 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.60842255 |
| 6 | Absent/shortened dynein arms (HP:0200106) | 4.60842255 |
| 7 | Visual hallucinations (HP:0002367) | 4.55129378 |
| 8 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.46610449 |
| 9 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.46610449 |
| 10 | Abnormal ciliary motility (HP:0012262) | 4.42303665 |
| 11 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.38740909 |
| 12 | Atonic seizures (HP:0010819) | 4.28985924 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 4.24989722 |
| 14 | Rhinitis (HP:0012384) | 4.19730120 |
| 15 | Nasal polyposis (HP:0100582) | 3.88010641 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.86612762 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.79433551 |
| 18 | Epileptic encephalopathy (HP:0200134) | 3.66092766 |
| 19 | Febrile seizures (HP:0002373) | 3.65061873 |
| 20 | Absence seizures (HP:0002121) | 3.60561530 |
| 21 | Cerebral inclusion bodies (HP:0100314) | 3.58466435 |
| 22 | Bronchiectasis (HP:0002110) | 3.53592255 |
| 23 | Chronic bronchitis (HP:0004469) | 3.45194765 |
| 24 | Action tremor (HP:0002345) | 3.44124916 |
| 25 | Dialeptic seizures (HP:0011146) | 3.37925618 |
| 26 | Abnormality of the nasal mucosa (HP:0000433) | 3.29960133 |
| 27 | Ankle clonus (HP:0011448) | 3.26359746 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 3.26310739 |
| 29 | Hyperactive renin-angiotensin system (HP:0000841) | 3.11597943 |
| 30 | Truncal ataxia (HP:0002078) | 3.03680760 |
| 31 | Dysmetria (HP:0001310) | 2.99344835 |
| 32 | Obstructive sleep apnea (HP:0002870) | 2.92678762 |
| 33 | Progressive inability to walk (HP:0002505) | 2.90736237 |
| 34 | Insidious onset (HP:0003587) | 2.90091437 |
| 35 | Termporal pattern (HP:0011008) | 2.90091437 |
| 36 | Scanning speech (HP:0002168) | 2.85117373 |
| 37 | Broad-based gait (HP:0002136) | 2.83517205 |
| 38 | Abnormality of the corticospinal tract (HP:0002492) | 2.82206500 |
| 39 | Papilledema (HP:0001085) | 2.69816626 |
| 40 | Hyperventilation (HP:0002883) | 2.69724198 |
| 41 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.64721958 |
| 42 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.64721958 |
| 43 | Limb dystonia (HP:0002451) | 2.64660571 |
| 44 | Pheochromocytoma (HP:0002666) | 2.63399638 |
| 45 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.62500487 |
| 46 | Intention tremor (HP:0002080) | 2.60218262 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 2.59500591 |
| 48 | Dysmetric saccades (HP:0000641) | 2.58842855 |
| 49 | Anxiety (HP:0000739) | 2.57275506 |
| 50 | Mutism (HP:0002300) | 2.56344595 |
| 51 | Spastic gait (HP:0002064) | 2.56204992 |
| 52 | Amblyopia (HP:0000646) | 2.54325151 |
| 53 | Bronchitis (HP:0012387) | 2.52914872 |
| 54 | Exotropia (HP:0000577) | 2.48355684 |
| 55 | Abnormal eating behavior (HP:0100738) | 2.47825823 |
| 56 | Dysdiadochokinesis (HP:0002075) | 2.47440087 |
| 57 | Recurrent sinusitis (HP:0011108) | 2.47123752 |
| 58 | Depression (HP:0000716) | 2.47046506 |
| 59 | Decreased circulating renin level (HP:0003351) | 2.45734052 |
| 60 | Urinary urgency (HP:0000012) | 2.45511879 |
| 61 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.44272735 |
| 62 | Ventricular fibrillation (HP:0001663) | 2.42902900 |
| 63 | Peripheral hypomyelination (HP:0007182) | 2.42139553 |
| 64 | Agitation (HP:0000713) | 2.39273176 |
| 65 | Postural instability (HP:0002172) | 2.37962297 |
| 66 | Diplopia (HP:0000651) | 2.37587738 |
| 67 | Abnormality of binocular vision (HP:0011514) | 2.37587738 |
| 68 | Recurrent otitis media (HP:0000403) | 2.36153494 |
| 69 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.35848452 |
| 70 | Drooling (HP:0002307) | 2.34632109 |
| 71 | Excessive salivation (HP:0003781) | 2.34632109 |
| 72 | Ulnar claw (HP:0001178) | 2.32547452 |
| 73 | Hyperkalemia (HP:0002153) | 2.29229514 |
| 74 | Neuroendocrine neoplasm (HP:0100634) | 2.28333609 |
| 75 | Poor eye contact (HP:0000817) | 2.28251922 |
| 76 | Abnormal social behavior (HP:0012433) | 2.24868392 |
| 77 | Impaired social interactions (HP:0000735) | 2.24868392 |
| 78 | Abnormality of renin-angiotensin system (HP:0000847) | 2.22077279 |
| 79 | Hyperaldosteronism (HP:0000859) | 2.21786844 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.20742856 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.20179209 |
| 82 | Hypothermia (HP:0002045) | 2.18344152 |
| 83 | Neuronal loss in central nervous system (HP:0002529) | 2.15726122 |
| 84 | Genetic anticipation (HP:0003743) | 2.14962897 |
| 85 | Blue irides (HP:0000635) | 2.14361425 |
| 86 | Syncope (HP:0001279) | 2.12463572 |
| 87 | Rapidly progressive (HP:0003678) | 2.10687513 |
| 88 | Onion bulb formation (HP:0003383) | 2.10627679 |
| 89 | Psychosis (HP:0000709) | 2.09589404 |
| 90 | Akinesia (HP:0002304) | 2.09348288 |
| 91 | Eczematoid dermatitis (HP:0000976) | 2.07616022 |
| 92 | Failure to thrive in infancy (HP:0001531) | 2.07374913 |
| 93 | Hyperthyroidism (HP:0000836) | 2.05619104 |
| 94 | Chronic otitis media (HP:0000389) | 2.01072275 |
| 95 | Lower limb muscle weakness (HP:0007340) | 2.00478210 |
| 96 | Plantar hyperkeratosis (HP:0007556) | 2.00122748 |
| 97 | Increased IgE level (HP:0003212) | 1.99877754 |
| 98 | Polyphagia (HP:0002591) | 1.98911789 |
| 99 | Milia (HP:0001056) | 1.98557902 |
| 100 | Malnutrition (HP:0004395) | 1.98011923 |
| 101 | Hypoplasia of dental enamel (HP:0006297) | 1.97358405 |
| 102 | Chronic sinusitis (HP:0011109) | 1.95627341 |
| 103 | Increased CSF protein (HP:0002922) | 1.94841425 |
| 104 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.94154511 |
| 105 | Onycholysis (HP:0001806) | 1.93559510 |
| 106 | Parakeratosis (HP:0001036) | 1.92307153 |
| 107 | Sensory axonal neuropathy (HP:0003390) | 1.90501906 |
| 108 | Abnormality of chloride homeostasis (HP:0011422) | 1.89481203 |
| 109 | Recurrent bronchitis (HP:0002837) | 1.89472446 |
| 110 | Epileptiform EEG discharges (HP:0011182) | 1.89094681 |
| 111 | Inability to walk (HP:0002540) | 1.88364965 |
| 112 | Stereotypic behavior (HP:0000733) | 1.87970760 |
| 113 | Growth hormone excess (HP:0000845) | 1.86364696 |
| 114 | Generalized myoclonic seizures (HP:0002123) | 1.85180708 |
| 115 | Dysostosis multiplex (HP:0000943) | 1.84101391 |
| 116 | Retinal dysplasia (HP:0007973) | 1.83675430 |
| 117 | Abnormality of salivation (HP:0100755) | 1.83168930 |
| 118 | Absent speech (HP:0001344) | 1.82297246 |
| 119 | Hypoventilation (HP:0002791) | 1.80606700 |
| 120 | Cerebral hemorrhage (HP:0001342) | 1.80485645 |
| 121 | Autoamputation (HP:0001218) | 1.80423304 |
| 122 | Rigidity (HP:0002063) | 1.80260277 |
| 123 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80043890 |
| 124 | Thick nail (HP:0001805) | 1.79903029 |
| 125 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79863087 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.79863087 |
| 127 | Abnormality of saccadic eye movements (HP:0000570) | 1.79599289 |
| 128 | EEG with generalized epileptiform discharges (HP:0011198) | 1.79052904 |
| 129 | Infertility (HP:0000789) | 1.78995901 |
| 130 | Slow saccadic eye movements (HP:0000514) | 1.78919904 |
| 131 | Megalencephaly (HP:0001355) | 1.78487696 |
| 132 | Adrenal overactivity (HP:0002717) | 1.78002774 |
| 133 | Hyperparathyroidism (HP:0000843) | 1.77868156 |
| 134 | Renal salt wasting (HP:0000127) | 1.77774532 |
| 135 | Glucose intolerance (HP:0000833) | 1.76576843 |
| 136 | Widely spaced teeth (HP:0000687) | 1.76077917 |
| 137 | Palmoplantar hyperkeratosis (HP:0000972) | 1.75574776 |
| 138 | Gait ataxia (HP:0002066) | 1.75349496 |
| 139 | Right ventricular cardiomyopathy (HP:0011663) | 1.74426362 |
| 140 | Bradycardia (HP:0001662) | 1.72864563 |
| 141 | Metabolic alkalosis (HP:0200114) | 1.72762601 |
| 142 | Inappropriate behavior (HP:0000719) | 1.71976186 |
| 143 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.71924215 |
| 144 | Male infertility (HP:0003251) | 1.71716234 |
| 145 | Abnormality of nail color (HP:0100643) | 1.71613360 |
| 146 | Hypercortisolism (HP:0001578) | 1.70850845 |
| 147 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.70821255 |
| 148 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.70821255 |
| 149 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.70821255 |
| 150 | Thickened helices (HP:0000391) | 1.70500461 |
| 151 | Bradykinesia (HP:0002067) | 1.69526439 |
| 152 | Torticollis (HP:0000473) | 1.68704432 |
| 153 | Abnormality of the periventricular white matter (HP:0002518) | 1.68410040 |
| 154 | Impaired smooth pursuit (HP:0007772) | 1.68044402 |
| 155 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.67823883 |
| 156 | Lip pit (HP:0100267) | 1.66984095 |
| 157 | Decreased motor nerve conduction velocity (HP:0003431) | 1.65032818 |
| 158 | Pili torti (HP:0003777) | 1.62619890 |
| 159 | Broad face (HP:0000283) | 1.62294572 |
| 160 | Abnormality of the axillary hair (HP:0100134) | 1.61077651 |
| 161 | Abnormality of secondary sexual hair (HP:0009888) | 1.61077651 |
| 162 | Increased cerebral lipofuscin (HP:0011813) | 1.60840182 |
| 163 | Abnormal glucose tolerance (HP:0001952) | 1.60415353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.82924229 |
| 2 | NTRK3 | 3.71660615 |
| 3 | EPHA4 | 2.73027618 |
| 4 | MAP3K4 | 2.61956360 |
| 5 | MAP3K12 | 2.56287649 |
| 6 | RIPK1 | 2.20996429 |
| 7 | MAP3K2 | 2.18074943 |
| 8 | MAP2K7 | 2.15390124 |
| 9 | NTRK1 | 2.11221005 |
| 10 | MINK1 | 2.04983069 |
| 11 | MARK1 | 2.03289599 |
| 12 | KSR2 | 2.03034191 |
| 13 | RIPK4 | 2.01390730 |
| 14 | STK39 | 1.92957505 |
| 15 | MAPK15 | 1.84309036 |
| 16 | CASK | 1.84080031 |
| 17 | MAP2K4 | 1.69223498 |
| 18 | EPHA2 | 1.67856633 |
| 19 | OXSR1 | 1.64185253 |
| 20 | DAPK2 | 1.59669868 |
| 21 | MAP3K3 | 1.58579263 |
| 22 | JAK1 | 1.55030625 |
| 23 | GRK5 | 1.54402234 |
| 24 | NTRK2 | 1.53082303 |
| 25 | MAPKAPK5 | 1.51115020 |
| 26 | CDK19 | 1.49423904 |
| 27 | PAK6 | 1.46162332 |
| 28 | MAPKAPK3 | 1.44518039 |
| 29 | MAP3K13 | 1.41403079 |
| 30 | CDK5 | 1.40833718 |
| 31 | TNIK | 1.33657352 |
| 32 | ERN1 | 1.32067882 |
| 33 | PNCK | 1.28319660 |
| 34 | STK24 | 1.27359046 |
| 35 | TRIB3 | 1.25880946 |
| 36 | LMTK2 | 1.22931479 |
| 37 | FGFR3 | 1.22745134 |
| 38 | RET | 1.18672408 |
| 39 | CAMKK1 | 1.16604521 |
| 40 | ARAF | 1.16434717 |
| 41 | TAOK2 | 1.15424671 |
| 42 | FER | 1.13651252 |
| 43 | NEK6 | 1.12093447 |
| 44 | CAMK2A | 1.11424300 |
| 45 | CAMK2B | 1.10293525 |
| 46 | TRPM7 | 1.09275135 |
| 47 | WNK1 | 1.09017543 |
| 48 | MAP3K11 | 1.08932704 |
| 49 | CAMKK2 | 1.07443648 |
| 50 | SGK494 | 1.07300010 |
| 51 | SGK223 | 1.07300010 |
| 52 | NLK | 1.05792291 |
| 53 | CSK | 1.04677938 |
| 54 | PAK3 | 1.03352462 |
| 55 | MAP3K14 | 1.01433118 |
| 56 | MAPK12 | 1.00650881 |
| 57 | FES | 1.00425853 |
| 58 | MAPK13 | 0.98829389 |
| 59 | MST4 | 0.98139059 |
| 60 | CDK12 | 0.97779003 |
| 61 | MAP3K1 | 0.97495574 |
| 62 | PLK2 | 0.96580147 |
| 63 | SIK2 | 0.93323614 |
| 64 | CSNK1G2 | 0.92985738 |
| 65 | BMPR2 | 0.91382610 |
| 66 | FGR | 0.91068139 |
| 67 | PHKG2 | 0.90935294 |
| 68 | PHKG1 | 0.90935294 |
| 69 | WNK4 | 0.90761955 |
| 70 | CAMK1G | 0.89919671 |
| 71 | UHMK1 | 0.89910266 |
| 72 | CAMK2D | 0.88321094 |
| 73 | GRK7 | 0.87239434 |
| 74 | PRKCH | 0.85878569 |
| 75 | MATK | 0.85374402 |
| 76 | KSR1 | 0.84194780 |
| 77 | PRKCE | 0.83151816 |
| 78 | STK11 | 0.82508257 |
| 79 | FRK | 0.80787149 |
| 80 | EPHB1 | 0.80576653 |
| 81 | ITK | 0.79421685 |
| 82 | PRKD3 | 0.78880713 |
| 83 | TESK1 | 0.78720334 |
| 84 | CDC42BPA | 0.78388635 |
| 85 | FGFR4 | 0.77083405 |
| 86 | PRKCG | 0.75707046 |
| 87 | SIK1 | 0.75603943 |
| 88 | TYK2 | 0.75277751 |
| 89 | PKN1 | 0.75213510 |
| 90 | MARK2 | 0.73467697 |
| 91 | STK38 | 0.73138417 |
| 92 | PDPK1 | 0.70858419 |
| 93 | PTK2B | 0.69939040 |
| 94 | TNK2 | 0.69355246 |
| 95 | CAMK2G | 0.68988498 |
| 96 | CAMK1 | 0.68351108 |
| 97 | JAK2 | 0.67940345 |
| 98 | DAPK1 | 0.67315277 |
| 99 | MAP4K1 | 0.66688956 |
| 100 | ERBB2 | 0.66119386 |
| 101 | NME1 | 0.65787527 |
| 102 | AKT3 | 0.65195191 |
| 103 | SGK1 | 0.63520465 |
| 104 | ZAP70 | 0.63091425 |
| 105 | FGFR2 | 0.62579271 |
| 106 | EEF2K | 0.62383209 |
| 107 | ROCK2 | 0.62346588 |
| 108 | SGK2 | 0.61418197 |
| 109 | BCR | 0.61071662 |
| 110 | PDK1 | 0.59882067 |
| 111 | EPHA3 | 0.59628008 |
| 112 | BLK | 0.58862319 |
| 113 | FYN | 0.57701874 |
| 114 | PDGFRB | 0.57252742 |
| 115 | SGK3 | 0.57060820 |
| 116 | HIPK2 | 0.56185338 |
| 117 | MAP3K7 | 0.55999239 |
| 118 | MAP2K6 | 0.55684175 |
| 119 | CDK14 | 0.55187458 |
| 120 | TBK1 | 0.53723833 |
| 121 | PRPF4B | 0.52587079 |
| 122 | CDK18 | 0.52510953 |
| 123 | CDK15 | 0.52165323 |
| 124 | DYRK1A | 0.51758640 |
| 125 | MAP2K1 | 0.50734405 |
| 126 | MAP2K3 | 0.50679682 |
| 127 | MST1R | 0.50169364 |
| 128 | MAPK7 | 0.49626599 |
| 129 | SCYL2 | 0.49504732 |
| 130 | TYRO3 | 0.49472509 |
| 131 | MAPK10 | 0.49015372 |
| 132 | PRKCQ | 0.48268370 |
| 133 | ALK | 0.48243817 |
| 134 | SYK | 0.47646716 |
| 135 | LATS2 | 0.47420985 |
| 136 | CSNK1G3 | 0.47361304 |
| 137 | CAMK1D | 0.47117206 |
| 138 | DMPK | 0.46789410 |
| 139 | TAOK1 | 0.46341665 |
| 140 | RAF1 | 0.43091834 |
| 141 | CDK11A | 0.42023300 |
| 142 | BMPR1B | 0.41103524 |
| 143 | PRKD1 | 0.40271013 |
| 144 | RPS6KA2 | 0.39528749 |
| 145 | TAOK3 | 0.38126981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.78863300 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.66792742 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.19689562 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.19547384 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.10823761 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.09730961 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.06875530 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.06440361 |
| 9 | Salivary secretion_Homo sapiens_hsa04970 | 1.99733205 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.98754453 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.95191644 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.86160592 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84830735 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.83459083 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.79284677 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.76583200 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.74339235 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.70950984 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.69613418 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.64408227 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.56490633 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.55599045 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55519106 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43353278 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39341061 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37374126 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35434299 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.35347343 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34230091 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29950550 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29686297 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29591569 |
| 33 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.27806827 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24898136 |
| 35 | Axon guidance_Homo sapiens_hsa04360 | 1.12878633 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11014931 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08728898 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.07833244 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04645847 |
| 40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04624229 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04499716 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04013126 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02986712 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02433451 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01272854 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97127814 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.96443848 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92430455 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 0.90911229 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90811430 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90135967 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86593437 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85501770 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.84726725 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.84704497 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82082538 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81498418 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78065855 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77821065 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77702361 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77271919 |
| 62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76882242 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.76822485 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76536652 |
| 65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76513970 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75794689 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75707400 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75393553 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.71773385 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71282493 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70406485 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69875807 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69818234 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69609119 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.68184883 |
| 76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67488930 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67043467 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.65210123 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64525414 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64331917 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63805716 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63636256 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63390141 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63309329 |
| 85 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63250920 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63193676 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62997978 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.61476833 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.61332684 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59015955 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58608192 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58268418 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57539645 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57121829 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.56699871 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56571390 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56549153 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56129058 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.55227571 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54734872 |
| 101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53625648 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52944298 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52142558 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51230019 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50418278 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49656201 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43804888 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43413040 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43015105 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.42200630 |
| 111 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.42187706 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.41554720 |
| 113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41414885 |
| 114 | Bile secretion_Homo sapiens_hsa04976 | 0.41238841 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41174803 |
| 116 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41065471 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38860909 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38142485 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37636236 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37291116 |
| 121 | Tight junction_Homo sapiens_hsa04530 | 0.36926374 |
| 122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36107866 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34511579 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.34184443 |
| 125 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.33963690 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.33307563 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32947959 |

